Showing results (1951-1960 of 2,090) with videos related to

Sort By:
Pageof 209
Circulation|March 29, 2006
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathyJ Peter van Tintelen, Mark M Entius, Zahurul A Bhuiyan, et al.
Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
Circulation. Arrhythmia and Electrophysiology|December 19, 2018
Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation: The I-VT ScorePasquale Vergara, Wendy S Tzou, Roderick Tung, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathyJohanna C Herkert, Kristin M Abbott, Erwin Birnie, et al.
Circulation. Arrhythmia and Electrophysiology|December 20, 2017
Ventricular Tachycardia Ablation in the Elderly: An International Ventricular Tachycardia Center Collaborative Group AnalysisKairav Vakil, Santiago Garcia, Roderick Tung, et al.
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
The New England Journal of Medicine|February 5, 2016
Antenatal Betamethasone for Women at Risk for Late Preterm DeliveryCynthia Gyamfi-Bannerman, Elizabeth A Thom, Sean C Blackwell, et al.
Scientific Reports|June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
International Journal of Molecular Sciences|February 25, 2023
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder VariantsMark Jansen, Maike Schuldt, Beau O van Driel, et al.
European Journal of Heart Failure|November 28, 2012
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriersIngrid A W van Rijsingen, Eline A Nannenberg, Eloisa Arbustini, et al.
Pageof 209